Clinical Factors Predicting Voluntary Driving Cessation among Patients with Parkinson’s Disease

Hidetada Yamada(Chugoku Rosai Hospital), Hirofumi Maruyama(Hiroshima University), Tomohisa Nezu(Hiroshima University), Yoshimasa Sueda(National Hospital Organization), Masahiro Nakamori(Hiroshima University), Tomohiko Ohshita, Teppei Kotozaki(Higashihiroshima Medical Center), Juri Kitamura
Behavioural Neurology
March 20, 2022
10.1155/2022/4047710
Cited by 4

Related Papers

Carotid Intima-Media Thickness for Atherosclerosis
|Journal of Atherosclerosis and Thrombosis|2015|311
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
|EBioMedicine|2015|124
Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy
|Stroke|2011|122
Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA
|Neurology|2010|106
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
|JAMA Neurology|2022|85